Your browser doesn't support javascript.
loading
Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials.
Rassy, Elie; Filleron, Thomas; Viansone, Alessandro; Lacroix-Triki, Magali; Rivera, Sofia; Desmoulins, Isabelle; Serin, Daniel; Canon, Jean Luc; Campone, Mario; Gonçalves, Anthony; Levy, Christelle; Cottu, Paul; Petit, Thierry; Eymard, Jean-Christophe; Debled, Marc; Bachelot, Thomas; Dalenc, Florence; Roca, Lise; Lemonnier, Jerôme; Delaloge, Suzette; Pistilli, Barbara.
Affiliation
  • Rassy E; Department of Cancer Medicine, University of Paris Saclay, Gustave Roussy, Villejuif, France.
  • Filleron T; BiostatisticsDepartment, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.
  • Viansone A; Department of Cancer Medicine, University of Paris Saclay, Gustave Roussy, Villejuif, France.
  • Lacroix-Triki M; Department of Biopathology, University of Paris Saclay, Roussy, Villejuif, France.
  • Rivera S; Department of Radiation Therapy, University of Paris Saclay, Gustave Roussy, Villejuif, France.
  • Desmoulins I; Department of Medical Oncology, Centre Oscar Lambret, Lille, France.
  • Serin D; Department of Medical Oncology, Institut Sainte-Catherine, Avignon, France.
  • Canon JL; Department of Medical Oncology, Grand Hôpital de Charleroi, Charleroi, Belgium.
  • Campone M; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Site René Gauducheau, Site Hospitalier Nord, Saint-Herblain, France.
  • Gonçalves A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
  • Levy C; Department of Medical Oncology, Centre François Baclesse, Caen, France.
  • Cottu P; Department of Medical Oncology, Institut Curie, Paris, France.
  • Petit T; Department of Medical Oncology, Centre Paul Strauss, Strasbourg, France.
  • Eymard JC; Department of Medical Oncology, Institut Godinot, Reims, France.
  • Debled M; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Bachelot T; Department of Medical Oncology, Centre Leon Berard, Lyon, France.
  • Dalenc F; Department of Medical Oncology, Institut Claudius Regaud, Institut Universitaire Cancer Toulouse-Oncopole, Toulouse, France.
  • Roca L; Institut Régional du Cancer de Montpellier, Parc Euromédecine, Montpellier, France.
  • Lemonnier J; R&D UNICANCER, UCBG, Paris, France.
  • Delaloge S; Department of Cancer Medicine, University of Paris Saclay, Gustave Roussy, Villejuif, France.
  • Pistilli B; Department of Cancer Medicine, University of Paris Saclay, Gustave Roussy, Villejuif, France. barbara.pistilli@gustaveroussy.fr.
Breast Cancer Res Treat ; 199(2): 371-379, 2023 Jun.
Article in En | MEDLINE | ID: mdl-36988749
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2023 Document type: Article Affiliation country: